Drug developpment Drug developpment
Select your search
Contact us
You are here : Non Clinical Studies

Non Clinical Studies: a Crucial Step

Non Clinical Studies Bertin Pharma

R&D in Pharmaceutical Companies is a critical issue in terms of investment and patent protection.

Every year, Pharmaceutical & Biotech companies screen 10,000 drugs.
Only 250 drugs reach pre-clinical phase.

The goals of non clinical studies are to assess the pharmacodynamics (PD), pharmacokinetics (PK), ADME and toxicity of drug/biotech candidates in animals.

A Crucial Step in terms of Risk Assessment prior first-in-man Clinical Trials

Indeed, due to rapid technology breakthroughs, preclinical studies can detect, in vitro and in vivo the compounds that have the less possible adverse effects to go to phase I studies. These data collected allows researchers to allometrically estimate a safe starting dose of drug for clinical trials.

Bertin Pharma offers services and expertise, in accordance with Good Laboratory Practice (GLP) and The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guidelines, including:


Bertin Pharma - Drug developpment

Follow Us

Linkedin Youtube Twitter Google+

Contact us

Any project? Any challenge? We are in!
+33 (0) 139 306 260
Any questions? Contact us

Parc d’Activités du Pas du Lac
10 bis avenue Ampère
78180 Montigny le Bretonneux - France
View our other locations


Do you want to be kept updated with Bertin Pharma's latest news?

Manage my subscriptions